![Ramiro Ribeiro](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/05/2026
Ramiro Ribeiro is currently Chief Medical Officer at EyePoint, Inc. since 2024.
Formerly, Dr. Ribeiro was Vice President & Head-Clinical Development at Apellis Pharmaceuticals, Inc. from 2018 to 2024.
Education includes doctorates from Universidade Federal De Sao Paulo and Pontificia Universidade Catolica Do Parana.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
EYEPOINT, INC. -.--% | 21/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| EYEPOINT, INC. | Director Técnico/Científico/I+D | 04/03/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/03/2024 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Apellis Pharmaceuticals, Inc.
 Apellis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics and drug delivery technologies to address chronic inflammatory diseases | Health Technology |
EyePoint Pharmaceuticals, Inc.
 EyePoint Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets ophthalmic pharmaceuticals | Health Technology |
Pontificia Universidade Catolica Do Parana
 Pontificia Universidade Catolica Do Parana Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universidade Federal De Sao Paulo
 Universidade Federal De Sao Paulo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
